Apixaban Versus Aspirin and Risk of Hemorrhage in the <scp>ARCADIA</scp> Trial
We found no increase in any hemorrhage type and a decrease in intracranial hemorrhage with apixaban relative to aspirin in patients with cryptogenic stroke and evidence of atrial cardiopathy. ANN NEUROL 2026.
Authors
- Pamela Plummer
- Noor Sabagha
- Abdalla Ammar (ORCID: https://orcid.org/0000-0002-1427-1173)
- Mitchell S. V. Elkind
- Jeff S Healey
- Qi Pauls
- David L Tirschwell
- Hooman Kamel
- W T Longstreth
- Ashkan Shoamanesh
- Babak B Navi
- Rebeca Aragon Garcia
- Richard A Kronmal
- Joseph P Broderick
- Kevin N Sheth
- for the ARCADIA Investigators
Institutions
- Yale New Haven Hospital (US)
- Medical University of South Carolina (US)
- University of Washington (US)
- Cornell University (US)
- Population Health Research Institute (CA)
- Yale University (US)
- MIND Research Institute (US)
- Cancer Research And Biostatistics (US)
- Columbia University (US)
- Sage Colleges (US)
- University of Cincinnati Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1002/ana.78186
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00